Stay updated with breaking news from Milo Bonser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interim Results for the six months ended 30 June 2022FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPSYProstate cancer partnership signed with Solaris HealthPositive ovarian cancer headline
Parsortix test successful in discriminating malignant and benign abnormal pelvic masses from a simple blood draw for detection of ovarian cancerBest in class results indicate the potential to reduce both
ANGLE plc STUDY USING PARSORTIX DEMONSTRATES IMPORTANCE OF BIOMARKER-INDEPENDENT CTC ISOLATION IN HEAD AND NECK CANCEREMT status of CTCs found to provide additional insight to tumour tissue biopsyPotential
Investegate announcements from Angle PLC, Study using Parsortix in head and neck cancer
ANGLE PRESENTS NEW POSTER AT AMERICAN SOCIETY FOR CLINICAL PATHOLOGY MEETINGPoster describes novel use of Pap stain procedure to analyse morphology of CTCs harvested using the Parsortix systemApproach